Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-02 Sale | 2023-06-02 6:15 pm | MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director | 8,638 | $23.01 | $198,760 | 40,493 (Direct) | View |
| 2022-06-06 Sale | 2022-06-06 7:20 pm | MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director | 6,424 | $19.25 | $123,673 | 33,980 (Direct) | View |
| 2021-06-17 Sale | 2021-06-17 5:41 pm | MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director | 3,139 | $30.52 | $95,795 | 23,129 (Direct) | View |
| 2021-05-28 Sale | 2021-06-01 7:15 pm | MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director | 7,142 | $28.99 | $207,023 | 13,420 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-02-07 9:58 pm | N/A 2031-04-26 | Kyverna Therapeutics Inc. | KYTX | SPIEGELMAN DANIEL K Director | 0 | $0 | 50,537 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 6:15 pm | N/A N/A | MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director | 15,151 | $0 | 40,493 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-26 5:40 pm | N/A 2033-05-24 | SPRUCE BIOSCIENCES INC. | SPRB | SPIEGELMAN DANIEL K Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 5:27 pm | N/A N/A | MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director | 17,275 | $0 | 40,404 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 4:12 pm | N/A 2032-05-24 | SPRUCE BIOSCIENCES INC. | SPRB | SPIEGELMAN DANIEL K Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-04 7:11 pm | N/A N/A | MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director | 12,848 | $0 | 26,268 (Direct) | View |
| 2021-05-27 Disposition | 2021-05-28 6:48 pm | N/A N/A | MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director | 15,889 | $0 | 20,562 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 9:11 pm | N/A 2031-05-19 | SPRUCE BIOSCIENCES INC. | SPRB | SPIEGELMAN DANIEL K Director | 6,667 | $0 | 6,667 (Direct) | View |
| 2020-12-04 Option Award | 2020-12-07 5:27 pm | N/A N/A | MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director | 15,889 | $0 | 36,451 (Direct) | View |
Ownership | 2020-11-18 8:16 pm | N/A N/A | Jiya Acquisition Corp. | JYAC | SPIEGELMAN DANIEL K Director | 0 | $0 | 30,000 (Direct) | View |
Ownership | 2020-10-08 9:08 pm | N/A 2030-09-08 | SPRUCE BIOSCIENCES INC. | SPRB | SPIEGELMAN DANIEL K Director | 0 | $0 | 34,398 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-28 11:17 am | N/A N/A | MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director | 20,562 | $0 | 20,562 (Direct) | View |
| 2019-04-30 Option Award | 2019-06-07 6:51 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | SPIEGELMAN DANIEL K EVP, Chief Financial Officer | 176 | $68.78 | 47,686 (Direct) | View |